While GDF11 was initially proposed as the major ligand of luspatercept, recent studies showing a lack of anemia improvement in the absence of GDF11 upon ineffective erythropoiesis suggest that other TGF‐β superfamily ligands are the functional targets of luspatercept. This evidence concerns the gene GDF11 and anemia (phenotype).